Krishna Institute of Medical Sciences Share Price

Krishna Institute of Medical Sciences Share Price

788.95
+24.05 (3.14%)
NSE: KIMS | BSE: 543308 | Healthcare | Small Cap | as on 05 Jun, 2026 • 03:29 PM IST
Buywith MTF at 3.24x leverage

Krishna Institute of Medical Sciences Annualised Returns

1 Year

19.47%

3 Years

35.23%

5 Years

32.11%

Krishna Institute of Medical Sciences Share Price Today


As of 6 Jun 2026, Krishna Institute of Medical Sciences share price is ₹789. The stock opened at ₹769.5 and had closed at ₹764.9 the previous day. During today’s trading session, Krishna Institute of Medical Sciences share price moved between ₹763.45 and ₹797.00, with an average price for the day of ₹780.23. Over the last 52 weeks, the stock has recorded a low of ₹575.80 and a high of ₹798.40. In terms of performance, Krishna Institute of Medical Sciences share price has increased by 12.1% over the past six months and has increased by 19.47% over the last year.

Krishna Institute of Medical Sciences Stock Performance

1W Return3.97
1Y Return20.60
Today's Low763.45
Prev. Close764.90
Mkt Cap (Cr.)31,568.96
1M Return16.64
3Y Return155.88
52-Week High798.4
Open769.50
PE Ratio121.12
6M Return12.07
Today's High797
52-Week Low575.8
Face Value2

Krishna Institute of Medical Sciences Share Price Chart

Krishna Institute of Medical Sciences Company background

Founded in: 1973
Krishna Institute of Medical Sciences Limited (KIMS) was erstwhile incorporated as Jagjit Singh and Sons Private Limited, a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, the name of the Company changed to Krishna Institute of Medical Sciences Private Limited on January 2, 2004 and further upon its conversion to a Public Company, the name was changed to Krishna Institute of Medical Sciences Limited on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh Maharashtra providing multidisciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It is engaged in rendering medical and healthcare services. It operate 12 multispecialty hospitals under the KIMS Hospitals brand, with an aggregate capacity of over 5000 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother child care.Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company.Led by Dr. Bhaskar Rao Bollineni, Managing Director and CEO of the Company, a renowned cardiothoracic surgeon, it has grown from a single hospital to a chain of multispecialty hospitals, both organically and through strategic acquisitions. The oldest hospital in their network was established in 2000 at Nellore, by its Corporate Promoter, BRMH, with a capacity of approximately 200 beds and, At present, the hospital network has grown to six multispecialty hospitals in six cities, with a total capacity of 4000 beds, including 1,705 operational beds. The Hospitals are equipped with stateoftheart medical equipment and employ practices and policies which help to provide quality healthcare services to their patients. It was one of the first hospitals in Hyderabad to install 4Arm HD da Vinci Robot technology at Secunderabad hospital. The flagship hospitals at Secunderabad and Rajahmundry have been accredited by the National Accreditation Board for Hospitals and Healthcare Providers, India (NABH). The Hospital at Secunderabad is accredited with ISO 9001:2008 certification and has also been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The Hospital situated at Secunderabad was awarded the Healthcare Excellence Award, by the Indo Global Healthcare Summit and Expo, in 2015. It has also received awards from the Association of Healthcare Providers (India) (AHPI) for nursing excellence, in 2015 and for Patient Friendly Hospital, in 2017. In 2017, it was awarded the best hospital of the year in the multispecialty hospital category in Hyderabad by Times Healthcare Achievers Awards and in 2016 received the Pharmacie DeQualite certification from Bureau Veritas. Further, it was the first hospital in Andhra Pradesh and Telangana to have been Green OT certified in 2016. It is also the laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 20152016. Neurology India Journal has ranked the neurology department at its hospital at Secunderabad as the third biggest centre in India on the basis of volume of epilepsy surgeries performed, as on July 31, 2016.In addition to healthcare services, the company also conduct medical education programmes through its affiliations with state medical boards and universities, for various broad and super specialties at its hospitals in Secunderabad and Rajahmundry, including for DNB, under graduation, postgraduation, PhD and diploma programmes. It is also affiliated with Kaloji Narayana Rao University of Health Sciences and the Andhra Pradesh Para Medical Board.During 2022, Sunshine Hospitals became subsidiary of the Company effective from April, 2022. In 202223, the Company opened an exclusive Gastroenterology unit at Vizag. During FY 202223, Sarvejana Healthcare Private Limited became a Subsidiary of the Company effective 01st April 2022 SPANV Medisearch Lifesciences Private Limited became the Subsidiary of Company on 01.09.2022. Suryateja Healthcare Private Limited has ceased to be step down subsidiary of the Company w.e.f. December 01, 2022.The Nagpur Hospital became functional in 2024. The Company acquired a running hospital of 200 bedsQUEENS NRI HOSPITAL in Vizag, Andhra Pradesh in Jul24.The Company opened two units at Kannur and Kollam in Kerala in FY25. The first liver transplantation in Rayalaseema region in Andhra Pradesh took place in KIMS hospitals at Kurnool. Similarly, another liver transplantation took place at KIMS in Srikakulam in 2025. Company launched a 300bed facility in Thane, Mumbai in April 2025. Company operationalised fullfledged units in Nashik and Sangli (Maharashtra), Kannur and Kollam (Kerala) and Guntur (Andhra Pradesh). It launched the second unit, at Seethammadhara, with a fertility centre, Paediatric and Childcare unit under the Cuddles brand and a specialty care centre. It introduced a foot care clinic and a rehabilitation facility in Hyderabad.

Krishna Institute of Medical Sciences Financial Highlights


For the full year FY2026–2027, revenue reached ₹3930.8 crore and profit touched at ₹239.4 crore. As of Mar '26, Krishna Institute of Medical Sciences’s market capitalisation stood at ₹31,568.96 crores. Shareholding as of Mar '26 shows promoters holding 34.1%, with FIIs at 14.6%, DIIs at 32.5%, and public at 18.8%.
Read More
Krishna Institute of Medical Sciences SIP Returns Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 7,43,706 in 5 years with a gain of 4,43,706 (+147.90%)

Krishna Institute of Medical Sciences Fundamental

Market Cap (in crs)

31,568.96

Face Value

2

Turnover (in lacs)

17,166.49

Key Metrics

Qtr Change %
Near 52W High of ₹798.40
12
Dividend yield 1yr %
0

Krishna Institute of Medical Sciences Key Financials

View more
Loading chart...
Krishna Institute of Medical Sciences Quarterly Revenue
Krishna Institute of Medical Sciences Yearly Revenue
Krishna Institute of Medical Sciences Quarterly Net Profit/Loss
Krishna Institute of Medical Sciences Yearly Net Profit/Loss

Krishna Institute of Medical Sciences Result Highlights

  • Krishna Institute of Medical Sciences reported a 8.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 35.3%.
  • Its expenses for the quarter were up by 9.3% QoQ and 50.6% YoY.
  • The net profit decreased 36.2% QoQ and decreased 68.8% YoY.
  • The earnings per share (EPS) of Krishna Institute of Medical Sciences stood at 1.06 during Q4 FY 2025-26.

Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Krishna Institute of Medical Sciences Technical Analysis

Moving Averages Analysis
788.95
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5 EMA
766.40
10 EMA
761.00
12 EMA
758.80
20 EMA
748.60
26 EMA
740.80
50 EMA
717.50
100 EMA
697.00
200 EMA
681.10
Delivery & Volume
Loading chart...

Day

44.70%

Week

48.90%

Month

51.50%

Delivery & Volume

783.13
Pivot
Resistance
First Resistance
802.82
Second Resistance
816.68
Third Resistance
836.37
Support
First Support
769.27
Second support
749.58
Third Support
735.72
Relative Strength Index
62.05
Money Flow Index
73.33
MACD
18.04
MACD Signal
19.73
Average True Range
28.84
Average Directional Index
28.96
Rate of Change (21)
12.66
Rate of Change (125)
14.33
Compare

Krishna Institute of Medical Sciences Shareholding Pattern

Promoter
34.1%
Foreign Institutions
14.6%
Mutual Funds
27.4%
Domestic Institutions
32.5%
Public
18.8%

Krishna Institute of Medical Sciences Latest News

05 JUN 2026
02 JUN 2026
01 JUN 2026

Krishna Institute of Medical Sciences share price is ₹788.95 in NSE and ₹789.7 in BSE as on 5/6/2026.

Krishna Institute of Medical Sciences share price in the past 1-year return was 20.59. The Krishna Institute of Medical Sciences share hit a 1-year low of Rs. 575.8 and a 1-year high of Rs. 798.4.

The market cap of Krishna Institute of Medical Sciences is Rs. 31568.96 Cr. as of 5/6/2026.

The PE ratios of Krishna Institute of Medical Sciences is 121.12 as of 5/6/2026.

The PB ratios of Krishna Institute of Medical Sciences is 13.01 as of 5/6/2026

The Mutual Fund Shareholding in Krishna Institute of Medical Sciences was 27.41% at the end of 5/6/2026.

You can easily buy Krishna Institute of Medical Sciences shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Krishna Institute of Medical Sciences share price is ₹798.4 and ₹575.8 as of 5/6/2026.

Please be aware that Krishna Institute of Medical Sciences stock prices are subject to continuous fluctuations due to various factors.